Edward J Usherwood

Author PubWeight™ 32.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J Immunol 2004 3.15
2 CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses. Proc Natl Acad Sci U S A 2009 2.01
3 Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines. Blood 2008 1.43
4 Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection. J Virol 2006 1.36
5 Recall responses by helpless memory CD8+ T cells are restricted by the up-regulation of PD-1. J Immunol 2009 1.34
6 Different functional capacities of latent and lytic antigen-specific CD8 T cells in murine gammaherpesvirus infection. J Immunol 2004 1.30
7 IL-15-independent proliferative renewal of memory CD8+ T cells in latent gammaherpesvirus infection. J Immunol 2004 1.30
8 Programmed death 1 regulates development of central memory CD8 T cells after acute viral infection. J Immunol 2011 1.29
9 Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor. Cancer Res 2007 1.24
10 Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response. J Immunol 2008 1.22
11 Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis. J Virol 2003 1.14
12 CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68. J Virol 2006 1.11
13 Cutting edge: IL-2 immune complexes as a therapy for persistent virus infection. J Immunol 2009 1.04
14 Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma. J Clin Invest 2011 1.03
15 Suppressive CD8+ T cells arise in the absence of CD4 help and compromise control of persistent virus. J Immunol 2011 1.02
16 CD8+ T cell dysfunction and increase in murine gammaherpesvirus latent viral burden in the absence of 4-1BB ligand. J Immunol 2007 1.01
17 Immune responses against persistent viral infections: possible avenues for immunotherapeutic interventions. Crit Rev Immunol 2008 0.99
18 MicroRNA miR-155 affects antiviral effector and effector Memory CD8 T cell differentiation. J Virol 2012 0.93
19 Tumor-specific T-cell memory: clearing the regulatory T-cell hurdle. Cancer Res 2008 0.92
20 Strain-dependent requirement for IFN-γ for respiratory control and immunotherapy in murine gammaherpesvirus infection. Viral Immunol 2011 0.90
21 Critical role for all-trans retinoic acid for optimal effector and effector memory CD8 T cell differentiation. J Immunol 2013 0.88
22 Murine gammaherpesvirus 68 LANA acts on terminal repeat DNA to mediate episome persistence. J Virol 2012 0.87
23 Immune escape of γ-herpesviruses from adaptive immunity. Rev Med Virol 2014 0.84
24 Differential requirements for CD80/86-CD28 costimulation in primary and memory CD4 T cell responses to vaccinia virus. Cell Immunol 2010 0.80
25 Regulatory CD8+ T cells associated with erosion of immune surveillance in persistent virus infection suppress in vitro and have a reversible proliferative defect. J Immunol 2013 0.79
26 Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recovery. J Clin Oncol 2010 0.79
27 CD4 and CD8 T cells directly recognize murine gammaherpesvirus 68-immortalized cells and prevent tumor outgrowth. J Virol 2013 0.79
28 T-cell responses to the M3 immune evasion protein of murid gammaherpesvirus 68 are partially protective and induced with lytic antigen kinetics. J Virol 2004 0.78
29 CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose. Cell Mol Immunol 2014 0.75